However, at least in FTD patients, the burden of TDP-43 pathology in the frontal cortex does not correlate with the expression levels of full-length STMN2 [30], raising the possibility that additional pathways contribute to dysregulation of STMN2 expression. This evidence concerns the gene TARDBP and frontotemporal dementia.